Pneumococcal Vaccine Study

Now Enrolling Children and Adolescents Age 2 to 17

Now Enrolling

About this research study

Pneumococcal disease, caused by a type of bacterium called Streptococcus pneumoniae, is a major cause of infections that may be in the ears, sinuses, blood, lungs, or brain. Researchers are studying an investigational vaccine that may provide protection against pneumococcal disease in children and adolescents with increased risk of pneumococcal disease.

Eligible participants...

  • Must be age 2 to 17
  • Must have a documented diagnoses of 1 or more of the following risk conditions for pneumococcal disease and have been receiving stable medical management for the risk conditions for at least 3 months:
    • Diabetes mellitus receiving treatment with antidiabetic medication
    • Chronic compensated liver disease
    • Chronic lung disease, including but not limited to asthma
    • Chronic heart disease due to heart failure, congenital heart disease, cardiomyopathy, and/or valvular heart disease
    • Chronic kidney disease, with chronic kidney insufficiency/impairment
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

This field is for validation purposes and should be left unchanged.
Name(Required)
Date of birth(Required)
Age can help us determine study eligibility (you must be age 18 or older to submit this form).
Race(Required)
Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.
This field is hidden when viewing the form

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Albuquerque, New Mexico • Velocity Clinical Research

3901 Carlisle Blvd NE, Albuquerque, NM 87107
Phone: (505) 243-1627

Salt Lake City (West Jordan), Utah • Velocity Clinical Research

3590 West 9000 South, Suite 300, West Jordan, UT 84088
Phone: (801) 542-8190

Gulfport, Mississippi • Velocity Clinical Research

15444 Dedeaux Road, Suite B, Gulfport, MS 39503
Phone: (228) 206-1283

Phoenix, Arizona • Velocity Clinical Research

555 N. 18th Street, Suite 100, Phoenix, AZ 85006
Phone: (602) 368-1928

Austin, Texas • Velocity Clinical Research

12515-2 Research Blvd, Suite 225, Austin, TX 78759
Phone: (512) 506-8287
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy